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Objective: Functionalmovement disorders (FMDs) fall within the broader category called functional neurological
symptom disorder (FNSD). New DSM-5 criteria for FNSD no longer require the presence of a ‘psychological
conﬂict’ suggesting that some patients with FMD may not have obvious psychological comorbidity. We studied
patients with FMD in comparison to patients with a neurological movement disorder (MD) and healthy controls
(HC) to identify whether there is a subgroup of patients with FMD who have normal psychological test scores.
Methods:We assessed self-ratedmeasures of depression/anxiety (SCL-90), dissociation and personality disorder
(PDQ-4) in patients attending neurological clinics and healthy controls. The proportion of patients scoringwithin
normal ranges was determined, and the levels of somatic and psychological symptomswere compared between
the three groups.
Results: Among the FMD group, 39% (20/51) scored within the normal range for all measures compared to 38%
(13/34) of MD subjects and 89% (47/53) of healthy controls. There were no differences in overall scores in the
SCL-90 and PDQ-4 between FMD and MD patients. FMD patients also did not differ from controls on a self-
rated measure of personality pathology.
Conclusion: Our data show that a substantial proportion of patients with FMD score within the normal range in
psychological questionnaires, lending some support to the new DSM-5 criteria.© 2015 Elsevier Inc. All rights reserved.Introduction
Debate about diagnostic criteria for functional neurological symp-
toms was revitalized with the advent of DSM-5 [1,2]. Functional neuro-
logical symptoms include neurological symptoms which are internally
inconsistent or incongruent with neurological disease but are not the
result of intentional feigning. The DSM-IV-TR criteria [3] for conversion
disorder required the presence of a ‘psychological stressor’ in linewith a
Freudian idea that these symptoms originate from a psychological
conﬂict. In DSM-5 ‘conversion disorder (functional neurological
symptom disorder (FNSD)’ the requirement for a psychological stressor
as a diagnostic criterion has been abandoned, although the potential
relevance of psychological factors are still highlighted in the text.roningen, P.O. Box 30.001, 9700
n der Hoeven).High levels of general psychopathology such as depression, anxiety,
abnormal coping strategies, personality disorders are typically reported
in a large proportion of patients with conversion disorder [4–13]. How-
ever, controlled studies of functional movement disorders and non-
epileptic seizures have at times struggled to show expected differences
in psychopathology [12,14,15]. In addition, the proportion of patients
without obvious psychological symptoms are sometimes not identi-
ﬁed in studies which typically only report mean values of self-rated
measures without extracting the proportion of patients that score
within normal ranges on psychological tests. In ICD-10, FMD are clas-
siﬁed within dissociative disorders. Dissociative symptoms have
been found to bemore common in patients with a range of functional
neurological disorders than controls in some studies [16] but not in
others [11,14,17].
Diagnostic criteria for functional movement disorders originating
from the neurological ﬁeld [18–21] have never required psychological
factors to be present. Those working in clinical neurology often
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In one survey of 519 neurologists, 50% of respondents reported that
psychiatrists, psychologists, or rehabilitation specialists sometimes
(35%), often (14%) or always (1%) question the neurologists' original
diagnosis and recommend the neurological basis for the disorder be
reconsidered.
This prospective study aimed to analyze the proportion of patients
scoring within normal limits on questionnaire tests of psychopathology
within a group of patients diagnosed with functional movement dis-
order (FMD, i.e. movement disorder or functional paresis) by move-
ment disorder neurologists (TvL). We compared these results to
patients with ‘neurological’ movement disorder (MD) to control for
the secondary effects of having a medical condition, and to healthy
controls (HC).
Method
Subjects
This study was approved by the Medical Ethical Committee at the
University Medical Centre Groningen, the Netherlands and performed
according to The Code of Ethics of the World Medical Association
(declaration of Helsinki; version Seoul 2008). 'Patients were recruited
from the outpatient neurology clinics of the University Medical Center
of Groningen (TvL). All patients gave informed written consent. The
clinical diagnosis wasmade after a neurological examination by neurol-
ogists specialized in movement disorders (TvL). Additional neurophys-
iological examination (motor-evoked potentials, electromyography)
and/or clinical neuroimaging (MRI, PET, SPECT, or CT) were carried
out at the discretion of the assessing neurologist. Questionnaires were
given to patients toﬁll out at home after their hospital visit andwere re-
collected bymail within the followingweeks. Two previous studies [6,7]
describe an initial subset of patients who participated in this study.
Additional patients with functional movement disorder (FMD) and
movement disorder (MD) were recruited between September 2011
and February 2012 at the Movement Disorders Outpatient Clinic of the
Department of Neurology of the University Medical Center Groningen.
The sample was not consecutive. All patients were diagnosed with
FMD or MD except for those where severe cognitive impairment was
evident. Healthy controls were included by asking the spouse of MD
patients to also ﬁll out the questionnaires themselves. They were only
included if they answered negatively to a question about whether
they were currently being treated for a mental disorder or chronic so-
matic illness. Patientswith a SCOPA-COG (screening for impairedmem-
ory, attention, visuospatial functions and executive functioning [23])
score of 22 or less were excluded (i.e. this cutoff indicates severely im-
paired cognitive functioning).
Procedure and materials
Psychological dissociative symptoms were assessed with the Dutch
version of the Dissociation Questionnaire (DIS-Q; [24]), including
four scales: (1) identity confusion, (2) loss of control, (3) amnesia, and
(4) heightened concentration/absorption.
The Somatoform Dissociation Questionnaire (SDQ-20; [25]) was
used as an inventory for somatic dissociative symptoms. ‘Somatic disso-
ciative symptoms’ is a synonym for ‘functional neurological symptoms’:
the questionnaire was developed based on the dissociative theory on
FNSD. It contains items such as ‘I am paralyzed for a while’ or ‘I have
an attack that resembles an epileptic ﬁt’.
General psychopathology was assessed with the Dutch version [26]
of the Symptom Check List (SCL-90; [27]), consisting of the following
subscales: somatization, sleeping disorders, agoraphobia, depression,
anxiety, inadequacy, sensitivity, hostility, and psychoneuroticism.
The level of personality pathology was screened by means of the
Personality Diagnostic Questionnaire (PDQ-4; [28]), including 12subscales (paranoid, schizoid, schizotypical, histrionic, narcissistic,
borderline, antisocial, avoidant, dependent, obsessive-compulsive, de-
pressive, passive-aggressive) as well as a total scale for personality
pathology.
Statistical analyses
Between-group differences in demographic variables were tested
for age and education (ANOVA), sex (Kruskal-Wallis), and diagnosis
(Chi-square). Means, SD, and percentage of clinically abnormal scores
were calculated for PDQ-4, SCL-90, DIS-Q, and SDQ-20 (total scores
and subscales) for each group (see Table 2).
Because data was collected in a clinical sample, missing data were
inevitable. As there was no evidence for systematically missing
values (i.e. missing at random), to obtain maximum power subjects
with missing data on one of the questionnaires were included in
our analyses.
The presence of clinically relevant psychological symptoms was
established by using published clinical norm scores for PDQ-4 (N25;
[29]), SCL-90 (males N131, females N150; [30]), DIS-Q (N2.5; [31]),
and SDQ-20 (N28; [32]). To provide a detailed psychological description
of our sample, the percentage of patients and controls that scored above
the normal scores (i.e. indicating presence of psychopathology)was cal-
culated for each questionnaire. Subsequently, we calculated the total
percentage that scored below the cutoff values on the DIS-Q, PDQ-4,
and SCL-90 for each patient group and the HC. The subgroup that was
identiﬁed in this way did not have any clinically relevant psychological
symptom scores on the questionnaires used and was of interest for our
main analysis (identifying subgroup with normal psychological test
scores).
Associations between psychological characteristics (dissociation,
general psychopathology, and personality pathology) were calculated
for all three groups (Pearson’s r).
The Kolmogorov–Smirnov test showed that not all variables were
normally distributed. However, we performed parametrical tests, as
MANOVA is known to be robust for deviations from normality. A
MANOVA was performed with diagnosis (FMD, MD, and HC) as group-
ing variable and the total SCL-90, PDQ-4, DIS-Q, and SDQ-20 scores as
dependent variables (n = 133). Post hoc analyses were performed
with univariate ANOVAs and LSD multiple comparisons if the
MANOVA showed a signiﬁcant effect, to investigate differences per
questionnaire and at group levels. Finally, to control for the effects of
personality psychopathology, and general psychological distress
MANCOVA was performed to include PDQ-4 and SCL-90 total scores
as covariates in the comparison of both groups on DIS-Q and SDQ-20
total scores. ANCOVAs and repeated contrasts were used as follow-up
analysis.
Results
Fifty-ﬁve participants with functional movement disorder (FMD), 34 participants
withmovement disorder (MD) and 52 healthy controls (HC)were included. Demographic
information, educational data, and symptom category are listed in Table 1. No signiﬁcant
differences were found in age, education, and sex in the three groups.
Table 2 shows the clinical scores on all psychological questionnaires in raw scores as
well as in percentage of subjects that fall into the clinically abnormal range. The FMD
and MD groups demonstrated a different range and proportion of different test scores
(Chi-square: 195.22, p b .001).
A subgroup of subjects was identiﬁed that scored within the normal range on the
DIS-Q, SCL-90, and PDQ-4 questionnaires: 39% (20 out of 51) of FMD subjects scored
within the normal range, 38% (13 out of 34) of MD subjects and 89% (47 out of 53) of
HC subjects on the questionnaires.
Psychological dissociation was consistently and signiﬁcantly related to general
psychopathology and also to symptoms of personality disorders within all three groups
(see Table 3 for signiﬁcant associations). Somatic and psychological dissociative symp-
toms were associated in the FMD group (r = 0.45, p b .001) and in normal controls
(r=0.32, p b 0.05), but not inMD (r=0.12, n.s.). Somatic dissociationwas related to psy-
chological functioning, as measured with the SCL-90 and PDQ-4, only in the FMD group
(see Table 3).
Table 3
Associations (two-sided Pearson’s r) between dissociative psychological symptoms and
other psychological symptoms such as general psychopathology (SCL-90) and personality
disorders (PDQ-4) for all groups.
Psychological Dissociation
DIS-Q
Somatic Dissociation
SDQ-20
r (p) r (p)
FMD⁎ SCL-90 .57 (.001) .37 (.008)
PDQ-4 .70 (.001) .39 (.005)
MD⁎ SCL-90 .71 (.001) ns
PDQ-4 .61 (.001) ns
HC⁎ SCL-90 .51 (.001) ns
PDQ-4 .47 (.001) .35 (.010)
⁎ FMD= functional movement disorders; MD=movement disorder; HC = healthy
controls.
Table 1
Demographic and illness characteristics of patients with functional movement disorder
(FMD; n= 51), movement disorder (MD; n= 34), and healthy controls (HC; n= 52).
FMD HC MD
Range Mean (SD) Range Mean (SD) Range Mean (SD)
Age 21–71 50.4 (14.1) 18–78 50.6 (11.2) 20–78 52.3 (10.5)
Educationa 2–7 4.6 (1.4) 1–7 5.0 (1.3) 1–7 4.9 (1.1)
Number (%)
Gender Male 19 (37%) 20 (38%) 17 (50%)
Female 32 (63%) 33 (62%) 17 (50%)
Diagnoses
Paralysis 10 (19.6%) 1 (3%)
Gait disorder 10 (19.6%) 0 (0%)
Dystonia 2 (4%) 5 (15%)
Myoclonus 16 (31.4 %) 1 (3%)
Tremor 10 (19.6%) 24 (71 %)
Seizure 3 (6%) 3 (9%)
a Education was assessed using a Dutch rating scale (minimum= 1= primary school
not ﬁnished; maximum= 7= university ﬁnished).
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(F (8,254) = 8.27, p b .001). Post hoc contrasts revealed that FMD patients showed el-
evated scores on measures for somatic dissociative symptoms (SDQ-20) and psychological
dissociative symptoms (DIS-Q) when compared to MD patients, but not on measures for
general psychopathology (SCL-90). MD patients scored higher on the questionnaire for
somatic dissociative symptoms and psychopathology than healthy controls but not on the
measure for psychological dissociative symptoms. There were no overall differences
between the groups on scores of personality pathology (PDQ-4; see Table 4).
The MANCOVA showed that overall group differences in the presence of somatic and
psychological dissociative symptoms were still present (F (4,254) = 5.24, p b .001) after
controlling for general psychopathology and personality pathology. Follow-up ANCOVAs
(see Table 5) however revealed that only somatic dissociative symptoms but not psycho-
logical dissociative symptoms were elevated in FMD compared to MD.Table 2
Mean score, standard deviation, and percentage of clinically abnormal scores on all questionna
FMDa MD
Mean (SD) Abnormal n (%) Mean
Questionnaire (range)
DIS-Q (1–5)b
Identity confusion (6%) 1.2 (0.26) 10 (20%) 1.2
Loss of control 1.6 (0.50) 11 (22%) 1.5
Amnesia 1.5 (0.47) 7 (14%) 1.3
Absorption 1.9 (0.65) 9 (18%) 1.5
Total 1.5 (0.33) – 1.3
SDQ-20 (20–100) 27.5 (7.2) 20 (39%) 24.4
SCL-90 (0–360)b
Agoraphobia 16.3 (6.33) 26 (51%) 13.2
Anxiety 10.5 (4.63) 9 (18%) 11.0
Depression 26.2 (8.62) 20 (39%) 25.1
Somatic complaints 25.6 (9.10) 27 (53%) 22.0
Insufﬁciency 17.1 (6.38) 22 (43%) 15.2
Distrust 25.1 (8.55) 13 (26%) 24.8
Hostility 7.3 (1.57) 9 (18%) 7.2
Sleep problems 6.5 (3.25) 11 (22%) 6.5
Other 13.0 (3.69) 23 (45%) 11.4
Total 147.3 (39) 24 (48%) 145.1
PDQ-4 (0–99)b
Paranoid 1.5 (1.41) 3 (6%) 1.0
Schizoid 1.6 (1.67) 9 (18%) 1.5
Schizotypical 1.3 (1.64) 2 (4%) 1.3
Histrionic 1.0 (0.98) – 0.9
Narcissistic 1.0 (1.10) – 0.9
Borderline 1.4 (1.42) 1 (2%) 1.3
Antisocial 0.3 (0.48) – 0.2
Avoidant 1.8 (1.85) 9 (18%) 1.7
Dependent 0.9 (1.25) – 0.9
Obsessive-compulsive 2.3 (1.45) 11 (22%) 2.1
Depressive 2.2 (1.60) 4 (8%) 1.8
Passive-aggressive 0.5 (0.83) – 0.7
Total 17.4 (9.45) 9 (18%) 16.2
a FMD = functional movement disorder; MD=movement disorder; HC = healthy control
b Abnormal scores on subscales were calculated using the criterion of ±2 SD from the meanDiscussion
The data indicate that abnormal psychological test scores are
common but not necessarily present in functional neurological symp-
toms. Among patients, 39% that were diagnosed by movement disorder
neurologists as FMD scored within the normal range on psychological
questionnaires measuring general psychopathology, personality disor-
ders, and psychological dissociation. This lends some support to the
idea in the new DSM-5 criteria for functional neurological disorders,
psychological symptoms may be present but do not have to be [33].
An analogy might be that a diagnosis of stroke should not be rejected
because the patient has never smoked or is not hypertensive. Our data
suggests that psychiatrists or psychologist should not reject a diagnosis
of FMD just because psychological testing is normal.ire (sub)scales of all three groups.
HC
(SD) Abnormal n (%) Mean (SD) Abnormal n (%)
(0.26) 4 (12%) 1.1 (0.16) 3
(0.41) 2 (6%) 1.4 (0.24) 1 (2%)
(0.26) 1 (3%) 1.2 (0.31) 2 (4%)
(0.48) – 1.7 (0.45) 3 (6%)
(0.29) – 1.3 (0.16) –
(4.8) 5 (15%) 20.9 (1.54) –
(5.47) 20 (59%) 9.8 (2.58) 3 (6%)
(4.30) 15 (44%) 8.8 (2.13) 2 (4%)
(8.76) 18 (53%) 18.8 (3.15) 3 (6%)
(8.00 25 (74%) 15.8 (3.50) 2 (4%)
(5.94) 17 (50%) 11.3 (2.70) 4 (8%)
(9.03) 11 (32%) 21.2 (3.91) 4 (8%)
(1.32) 7 (21%) 6.5 (0.80) 2 (4%)
(3.31) 18 (53%) 4.3 (1.92) 3 (6%)
(3.18) 13 (38%) 10.0 (1.35) 4 (8%)
(36.8) 11 (34%) 106.3 (14.9) 1 (2%)
(1.16) 1 (3%) 1.3 (1.20) 3 (6%)
(1.62) 3 (9%) 1.3 (1.40) 4 (8%)
(1.52) 1 (3%) 1.2 (1.40) 1 (2%)
(1.27) – 1.1 (1.13) 1 (2%)
(1.15) – 0.8 (0.88) –
(1.24) – 0.8 (0.84) –
(0.46) – 0.3 (0.49) –
(2.10) 7 (21%) 1.2 (1.36) 5 (9%)
(1.47) 1 (3%) 0.5 (0.75) –
(1.67) 6 (18%) 2.1 (1.70) 14 (26%)
(1.75) 3 (9%) 1.4 (1.32) 1 (3%)
(1.15) 1 (3%) 0.5 (0.67) –
(12.34) 8 (24%) 14 (8.36) 5 (9%)
s.
in the HC group.
Table 4
MANOVA results: between group differences on the DIS-Q, SDQ-20, SCL-90, and PDQ-
4 total scores. For the PDQ-4, no pairwise comparisons could be made because the
overall test did not show a signiﬁcant effect.
ANOVAs Post hoc pairwise comparisons (Fisher’s LSDs)
F(2,130) p ⁎FMD-MD p FMD-HC p MD-HC p
DIS-Q 6.86 b .0010 0.13 b .05 0.19 b .001 0.06 n.s.
SDQ-20 22.85 b .0001 3.74 b .01 6.76 b .001 3.02 b .050
SCL-90 21.68 b .0001 9.39 n.s. 41.13 b .001 31.73 b .001
PDQ-4 1.92 n.s.
⁎ FMD= functional movement disorders; MD=movement disorder; HC = healthy
controls.
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functional neurological disorders usually present mean scores and
group differences and the proportion of individuals with normal test
scores are typically not identiﬁed. In addition, psychological distress is
also commonly present in patients with recognized neurologic disor-
ders [13,34] and therefore not speciﬁc for FMD, as illustrated earlier
by case control studies of FMD and non-epileptic seizures with ‘organic’
control groups [12,14,15,35]. Our data supported these reports as the
psychological proﬁle of patients with FMD resembled patients with rec-
ognized neurological symptoms in terms of elevated scores on general
psychopathology such as depression or anxiety and psychological disso-
ciative symptoms compared to healthy controls. FMD patients differed
from MD patients in terms of higher scores on a questionnaire for so-
matic dissociative symptoms. Also, while psychological dissociative
symptoms are related to general psychological symptoms in all three
groups, only the FMD group showed an association between somatic
dissociative symptoms and psychological symptoms at the test level.
Contemporarymodels offer an interesting synthesis of psychological
factors such as attention, the feeling of self-agency, and disturbed per-
ception of bodily events that lead to a unique form of involuntariness
[19,36–38]. For example, a model of functional movement disorder
has been proposed by Edwards et al. [17], in which the core problem
is deﬁned as a disorder of attention and belief interactingwith abnormal
attribution of bottom-up sensory information. According to this model,
patients experience a mismatch between beliefs and expectations and
sensory information associated with the symptom. This leads to a feel-
ing of lack of self-agency. In this model, the presence of psychological
stressors, emotional symptoms, or psychological dissociative symptoms
can be seen as additive but not essential to the development of
symptoms.
Limitations
Scores on psychological questionnaires are not a substitute for psy-
chiatric diagnosis by interview and it is likely that some of our ‘normal’
population would have had psychological or personality problems not
detected by questionnaires [13]. We also cannot exclude the possibility
of misdiagnosis, factitious disorder, or malingering in the FMD group.
Patients were diagnosed by experienced movement disorder neurolo-
gists and studies of misdiagnosis in a number of neurological centres
suggest that misdiagnosis of organic diseases is rare [39,40]. As these
are clinical data, patients were not asked consecutively and not allTable 5
MANCOVA results: between group differences on the DIS-Q and SDQ-20, controlled for
SCL-90 and PDQ-4.
ANCOVAs Post hoc pairwise comparisons (repeated contrasts)
F(2,127) p FMD-MDa p FMD-HC p MD-HC p
DIS-Q 2.11 n.s.
SDQ-20 9.42 b .001 3.25 b .001 4.63 b .001 1.38 n.s.
a FMD = functional movement disorders; MD =movement disorder; HC = healthy
controls.patients agreed for various reasons. Also, some of our healthy control
subjects were relatives of patients with a recognized neurological disor-
der. This means that they are not, strictly speaking, 'healthy' and their
psychological scores could have been contaminated because they
were living with someone who had a movement disorder. However,
to determine the proportion of patients with normal test scores, we
used clinical cutoff scores, as they are applied in clinical practice. Finally,
the data regarding somatoform dissociation are only of value in
assessing the differences in scores on somatoform dissociation in pa-
tients with functional movement disorder and normal controls. Note
that in patients with ‘neurological’ movement disorder, the SDQ result
is confounded by the presence of neurological disease causing
symptoms.
In conclusion, our data illustrates that patients with FMD form a
heterogeneous group in terms of psychological symptoms with over
one-third of patients scoring within normal ranges on questionnaires.
Although there aremany limitations to this ﬁnding, it should encourage
clinicians to take a less rigid view of the role of psychological factors in
FMD. Assessment of psychiatric diagnosis nevertheless remains an es-
sential part of formulation and treatment for most patients with FMD.
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